Survodutide
Survodutide — dual GLP-1/glucagon agonist. Phase 3 results, MASH data, weight loss, and sourcing.
Topic
Replies
Views
Last Post
12
2669
2026-10-05
Survodutide — dual GLP-1/glucagon agonist. Phase 3 results, MASH data, weight loss, and sourcing.